How many drugs treat Malignant tumor of esophagus?

Drug Landscape tracks 4 marketed treatments for Malignant tumor of esophagus (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-tumor-of-esophagus.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Malignant tumor of esophagus — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant tumor of esophagus (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant tumor of esophagus, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Opdivo	nivolumab	Bristol-Myers Squibb	Programmed Death Receptor-1 Blocking Antibody [EPC]	Programmed cell death protein 1	2014-01-01
Photofrin	porfimer	Concordia Labs Inc	Photoactivated Radical Generator		1995-01-01
Photofrin	Photofrin	Samsung Medical Center
Photodyn	Hematoporphyrin	Hepatopancreatobiliary Surgery Institute of Gansu Province	hematoporphyrin

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Bristol-Myers Squibb · 1 drug in Malignant tumor of esophagus
Concordia Labs Inc · 1 drug in Malignant tumor of esophagus
Hepatopancreatobiliary Surgery Institute of Gansu Province · 1 drug in Malignant tumor of esophagus
Samsung Medical Center · 1 drug in Malignant tumor of esophagus

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant tumor of esophagus:

Cite this brief

Drug Landscape (2026). Malignant tumor of esophagus — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-tumor-of-esophagus. Accessed 2026-06-10.

Malignant tumor of esophagus full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing